Ophiomics @ EASL Congress 2025 in Amsterdam 🌷 

We had the opportunity to showcase HepatoPredict and introduce our future screening tools for Hepatocellular Carcinoma (HCC) and MASLD. It’s exciting to contribute with new solutions that can make a difference in liver disease healthcare.

A huge thank you to EASL for organizing such a dynamic and impactful event, and to all the attendees and collaborators who engaged with us. We look forward to continuing these conversations and building meaningful partnerships.

See you in Barcelona next year!